4//SEC Filing
McKenzie Kathryn B 4
Accession 0001077183-20-000030
CIK 0001077183other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 8:00 PM ET
Size
12.7 KB
Accession
0001077183-20-000030
Insider Transaction Report
Form 4
McKenzie Kathryn B
Principal Accounting Officer
Transactions
- Award
Common Stock
2020-03-02+5,824→ 7,929 total - Tax Payment
Common Stock
2020-03-01−168→ 2,105 total - Award
Common Stock
2020-03-02$28.33/sh+37,514$1,062,772→ 37,514 totalExercise: $28.33From: 2021-03-02Exp: 2027-03-02→ Common Stock (37,514 underlying)
Holdings
- 40,000
Stock Option (Right to Buy)
Exercise: $8.03From: 2019-02-26Exp: 2023-02-26→ Common Stock (40,000 underlying) - 25,000
Stock Option (Right to Buy)
Exercise: $9.07From: 2018-10-17Exp: 2022-10-18→ Common Stock (25,000 underlying) - 13,894
Stock Option (Right to Buy)
Exercise: $19.60From: 2020-03-01Exp: 2024-03-01→ Common Stock (13,894 underlying)
Footnotes (5)
- [F1]Shares withheld by NeoGenomics Inc. to satisfy the tax obligations in connection with the March 1, 2020 vesting of restricted stock.
- [F2]On October 17, 2017, Ms. McKenzie was granted 25,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.
- [F3]On February 26, 2018, Ms. McKenzie was granted 48,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.
- [F4]On March 1, 2019, Ms. McKenzie was granted 13,894 stock options. These options vest ratably over the first four anniversary dates of the grant date.
- [F5]On March 2, 2020, Ms. McKenzie was granted 37,514 stock options. These options vest ratably over the first four anniversary dates of the grant date.
Documents
Issuer
NEOGENOMICS INC
CIK 0001077183
Entity typeother
Related Parties
1- filerCIK 0001720001
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 8:00 PM ET
- Size
- 12.7 KB